Endpoints News15m
No­vo Nordisk, HHS clash over ‘ne­go­ti­a­tion-el­i­gi­ble’ drugs in IRA ap­peals fight
Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in a case that will consider the extent to ...